JHS Svendgaard FY26 Revenue Rises 10.5%, Net Loss Narrows To Rs 1.9 Cr

CONSUMER-PRODUCTS
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
JHS Svendgaard FY26 Revenue Rises 10.5%, Net Loss Narrows To Rs 1.9 Cr

JHS Svendgaard Laboratories reported a 10.5% growth in annual revenue to Rs 101.69 crore for FY 2025-26. The company successfully narrowed its net loss to Rs 1.91 crore, down from Rs 19.73 crore in the previous fiscal year, signaling improved operational efficiency. The board has re-appointed key management, including Managing Director Nikhil Nanda, to lead the company for another five-year term.

JHS Svendgaard FY26 Revenue Hits Rs 101.69 Crore, Losses Narrow Significantly

Revenue grew by 10.5% year-on-year to Rs 101.69 crore, while the net loss narrowed sharply to Rs 1.91 crore.

Reader Takeaway: Strong top-line growth and loss reduction drive momentum, but internal control gaps remain a primary watch point.

What just happened

JHS Svendgaard Laboratories released its annual financial results for FY 2025-26. The company reported a substantial turnaround in its bottom line, reducing its net loss from Rs 19.73 crore in the previous year to just Rs 1.91 crore. Revenue saw a healthy uptick to Rs 101.69 crore, compared to Rs 92.00 crore in the prior fiscal period.

Why this matters

The dramatic 90% reduction in losses highlights improved operational efficiency and a better cost-management structure. Investors are observing this progress as the company shifts toward profitability, bolstered by a 10.5% rise in operational revenue.

Management and Board Changes

The company has finalized key leadership continuity. Nikhil Nanda has been re-appointed as Managing Director for a five-year term starting July 2, 2025. Additionally, Independent Directors Rajagopal Chakravarthi Venkateish and Kapil Minocha received five-year re-appointments, while Mukul Pathak concluded his tenure as an Independent Director.

Business Strategy

JHS Svendgaard is aggressively expanding its footprint in the CSD (Canteen Stores Department) segment. The portfolio for this channel has increased from 4 to 12 products. The firm continues to emphasize its fully integrated manufacturing capabilities across oral care and personal care categories.

Risks to watch

Auditors issued an unmodified opinion but raised concerns regarding internal financial controls. Specifically, they noted deficiencies in the monitoring and reconciliation of trade receivables and payables, alongside the lack of automated payment alerts in the current ERP system. Additionally, there remains a dispute regarding the possession of land in Kheri, Himachal Pradesh, which the company previously agreed to sell.

What to track next

Shareholders should monitor management's progress in upgrading ERP systems to address auditor feedback on internal controls and any updates regarding the disposal of the Kheri land assets.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.